专题：Biological Agents for Bioterrorism

This cluster of papers focuses on the study of biological agents with potential for bioterrorism, including anthrax, tularemia, Bacillus cereus, and Francisella tularensis. The research covers various aspects such as pathogenesis, genomic analysis, inhalational anthrax cases, toxins, and public health assessments related to these biological agents.
最新文献
Ebola vaccine: Oxford starts UK trial against Bundibugyo strain

article Full Text OpenAlex

The spread of sexually transmissible drug-resistant shigellosis in England: a genomic epidemiology study

article Full Text OpenAlex

Differential signaling roles of the KinA-KinE sensor kinases in regulating Spo0A, the master regulator of Bacillus subtilis cell‑fate decisions

article Full Text OpenAlex

Rebuilding community trust after attacks on Ebola treatment facilities in DRC: lessons from previous epidemics

article Full Text OpenAlex

Epidemiological and antimicrobial resistance characteristics of recent (2021–2024) Chinese Actinobacillus pleuropneumoniae clinical isolates

article Full Text OpenAlex

Race begins to trial Ebola drugs amid current outbreak

article Full Text OpenAlex

Optimized SPE–UPLC–MS/MS Method for Sensitive Determination of Cereulide in Complex InfantFormula Matrices

article Full Text OpenAlex

How Bacillus thuringiensis kills its insect host

article Full Text OpenAlex

Engineered bispecific antibodies achieve broad and potent protection against multiple ebolavirus species

article Full Text OpenAlex

New meningitis B outbreak: Three cases in Dorset are not linked to recent Kent wave

article Full Text OpenAlex

近5年高被引文献
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

article Full Text OpenAlex 1026 FWCI95.9277

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

article Full Text OpenAlex 861 FWCI81.8224

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

article Full Text OpenAlex 851 FWCI77.8027

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

article Full Text OpenAlex 754 FWCI71.2468

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

article Full Text OpenAlex 707 FWCI66.1696

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex

article Full Text OpenAlex 698 FWCI64.6876

Prevention and Treatment of Monkeypox

article Full Text OpenAlex 656 FWCI45.5844

SARS-CoV-2 Omicron variant: recent progress and future perspectives

article Full Text OpenAlex 638 FWCI57.7495

Monkeypox

article Full Text OpenAlex 578 FWCI37.1322

Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022

article Full Text OpenAlex 577 FWCI40.5275